asthma News
Most Popular asthma Story
SkyePharma files for Flutiform approval
In what CEO Ken Cunningham called a "major milestone," the UK's SkyePharma filed for FDA approval of its asthma drug Flutiform. Flutiform is SkyePharma's biggest drug prospect, with estimated annual... Read more...
Latest Headlines
- January 21, 2010
- October 27, 2009
- September 1, 2009
- March 23, 2009
- February 24, 2009
- June 5, 2008
- May 2, 2008
- February 4, 2008
- January 31, 2008
- January 25, 2008
- August 15, 2007
- May 30, 2006
- April 2, 2006
- December 11, 2005
- November 14, 2005
- July 13, 2005
Paid Research Reports
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities
- Investigating Clinical Trial Costs: Comparative analysis of trial cost components in key geographies
- Clinical Trial Recruitment Strategies: Optimizing patient recruitment and retention in late stage clinical trials
- Pipeline Insight: Therapeutic Cancer Vaccines - Prospect of first approval set to reinvigorate interest from major companies
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession
